The Greenfield-based animal health unit has posted more than a half-billion dollars in losses in the past three years, and it will face huge new corporate expenses as it goes its separate way after more than a half-century as part of Eli Lilly and Co.
The drug, launched in 2014, is one of Lilly's fastest-growing medicines, but its fate could hinge on the results of another clinical trial for heart benefits. The Indianapolis-based drugmaker plans to release results later this year.
The state's largest health system currently does not have any hospitals in northeast Indiana, but is gradually expanding its presence in Fort Wayne in response to turmoil at the region's largest health provider, Lutheran Health Network.
A method to pair commercially available soft contact lenses with bio-compatible sensors could lead to a device that will help doctors better manage ocular disease and monitor other biological changes in their patients.